Cipla gains as its arm enters into definitive agreement with Biopharma SPA

09 Oct 2015 Evaluate

Cipla is currently trading at Rs. 686.40, up by 8.40 points or 1.24 % from its previous closing of Rs. 678.00 on the BSE.

The scrip opened at Rs. 682.40 and has touched a high and low of Rs. 687.00 and Rs. 679.20 respectively. So far 66417 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 752.45 on 10-Mar-2015 and a 52 week low of Rs. 571.05 on 14-Oct-2014.

Last one week high and low of the scrip stood at Rs. 688.00 and Rs. 635.05 respectively. The current market cap of the company is Rs. 55105.04 crore.

The promoters holding in the company stood at 36.79%, while Institutions and Non-Institutions held 34.30 % and 26.60 % respectively.

Cipla’s wholly owned subsidiary - Cipla (EU), has entered into a definitive agreement with Biopharma SPA for establishing a joint venture company in Algeria.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

 

Cipla Share Price

1490.70 -6.75 (-0.45%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×